DJIA 17,055.87 -116.81 -0.68%
NASDAQ 4,508.69 -19.00 -0.42%
S&P 500 1,982.77 -11.52 -0.58%
market minute promo

115.95 -0.33 (-0.28%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $115.95 -0.28%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $114.45
Previous Close $116.28
Daily Range $114.00 - $117.84
52-Week Range $102.30 - $153.10
Market Cap $38.9B
P/E Ratio -49.48
Dividend (Yield) $0.00 (0.0%)
Volume 3,652,251
Average Daily Volume 2,109,884
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

3 Questions for Allergan Inc.

Allergan is fighting tooth and nail to remain independent from Valeant Pharmaceuticals. Here are three questions investors should know the answers to heading into what is looking like the endgame.

In the news: Apple sells 10 million iPhones, Allergan considers a deal for Salix and more

Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.

Allergan And Valeant: Lessons From The Go-Go Years

Why It's Time for Allergan Shareholders to Take Some Profits

Foamix Pharmaceuticals IPO Merits Serious Investor Consideration

Pershing Square Submiterd Additional Special Meeting Requests On Friday, Total Submitted Represents

Pershing Square Submiterd Additional Special Meeting Requests On Friday, Total Submitted Represents 35.68% Of Allergan Shares

Will Allergan's Board Be Revamped to Aid Valeant Buyout? - Analyst Blog

William Ackman Sends Letter To Allergen Board

Valeant: One Big Injection

Allergan OKs Special Shareholder Meeting Consents

See More VRX News...

VRX's Top Competitors

VRX $115.95 (-0.28%)
Current stock: VRX
RHHBY $37.57 (-0.25%)
Current stock: RHHBY
JNJ $107.46 (-0.39%)
Current stock: JNJ
PFE $30.05 (-0.43%)
Current stock: PFE